NCX 701

Drug Profile

NCX 701

Alternative Names: nitro-paracetamol; NO-paracetamol

Latest Information Update: 31 Jul 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NicOx
  • Class Acetanilides; Analgesics; Anti-inflammatories; Nitrates; Small molecules
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 27 Jul 2012 Discontinued - Phase-II for Pain in USA (PO)
  • 04 Aug 2010 NicOx to close its headquarters in the USA on August 31, 2010
  • 04 Aug 2010 NCX 701 is available for licensing worldwide (http://www.nicox.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top